Trade Summary

2 days ago, Michaelson Jennifer, serving as Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 1,780 shares at $14.14 per share, for a total transaction value of $25,169.00. Following this transaction, Michaelson Jennifer now holds 174,844 shares of CGEM.

This sale represents a 1.00% decrease in Michaelson Jennifer's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.

Cullinan Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.